Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
Egypt
· Delayed Price · Currency is EGP 7.90
+0.34 (4.50%)
At close: Apr 23, 2025
EGX:CLHO Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 5,420 | 3,595 | 2,584 | 2,549 | 1,990 | Upgrade
|
| Revenue Growth (YoY) | 50.76% | 39.13% | 1.36% | 28.13% | 10.64% | Upgrade
|
| Cost of Revenue | 3,407 | 2,387 | 1,719 | 1,619 | 1,300 | Upgrade
|
| Gross Profit | 2,013 | 1,209 | 865.27 | 930.67 | 689.57 | Upgrade
|
| Selling, General & Admin | 749.8 | 494.19 | 376.47 | 344.94 | 256.45 | Upgrade
|
| Other Operating Expenses | 50.93 | 10.46 | 14.51 | 11.96 | 18.44 | Upgrade
|
| Operating Expenses | 851.56 | 551.86 | 419.36 | 402.87 | 327.36 | Upgrade
|
| Operating Income | 1,162 | 656.76 | 445.91 | 527.79 | 362.22 | Upgrade
|
| Interest Expense | -122.05 | -69.55 | -35.72 | -34.44 | -2.16 | Upgrade
|
| Interest & Investment Income | 35.15 | 25.02 | 37.08 | 59.59 | 49.14 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.78 | 2.78 | 8.42 | -0.01 | -0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -3.29 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 1,083 | 611.71 | 455.68 | 552.93 | 408.91 | Upgrade
|
| Merger & Restructuring Charges | -0.9 | -2.3 | -4.29 | -17.52 | -13.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.91 | -0.32 | 0.21 | -0.79 | 0.48 | Upgrade
|
| Pretax Income | 1,084 | 609.09 | 451.6 | 534.62 | 396.22 | Upgrade
|
| Income Tax Expense | 266.65 | 135.53 | 93.37 | 123.95 | 98.58 | Upgrade
|
| Earnings From Continuing Operations | 817.01 | 473.56 | 358.23 | 410.67 | 297.65 | Upgrade
|
| Earnings From Discontinued Operations | - | -4.26 | -1.5 | - | - | Upgrade
|
| Net Income to Company | 817.01 | 469.3 | 356.73 | 410.67 | 297.65 | Upgrade
|
| Minority Interest in Earnings | -93.67 | -51.12 | -30.97 | -23.43 | -10.72 | Upgrade
|
| Net Income | 723.35 | 418.18 | 325.76 | 387.25 | 286.92 | Upgrade
|
| Preferred Dividends & Other Adjustments | 156.06 | 98.6 | 67.95 | 66.13 | 47.21 | Upgrade
|
| Net Income to Common | 567.29 | 319.58 | 257.81 | 321.12 | 239.71 | Upgrade
|
| Net Income Growth | 72.97% | 28.37% | -15.88% | 34.97% | 11.47% | Upgrade
|
| Shares Outstanding (Basic) | 1,442 | 1,442 | 1,515 | 1,599 | 1,600 | Upgrade
|
| Shares Outstanding (Diluted) | 1,444 | 1,444 | 1,517 | 1,599 | 1,600 | Upgrade
|
| Shares Change (YoY) | - | -4.82% | -5.11% | -0.08% | - | Upgrade
|
| EPS (Basic) | 0.39 | 0.22 | 0.17 | 0.20 | 0.15 | Upgrade
|
| EPS (Diluted) | 0.39 | 0.22 | 0.17 | 0.20 | 0.15 | Upgrade
|
| EPS Growth | 77.27% | 30.17% | -15.50% | 33.50% | 13.20% | Upgrade
|
| Free Cash Flow | -1,204 | -267.2 | 15.19 | 365.99 | -230.21 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -0.18 | 0.01 | 0.23 | -0.14 | Upgrade
|
| Gross Margin | 37.14% | 33.62% | 33.48% | 36.51% | 34.66% | Upgrade
|
| Operating Margin | 21.43% | 18.27% | 17.26% | 20.70% | 18.21% | Upgrade
|
| Profit Margin | 10.47% | 8.89% | 9.98% | 12.60% | 12.05% | Upgrade
|
| Free Cash Flow Margin | -22.21% | -7.43% | 0.59% | 14.36% | -11.57% | Upgrade
|
| EBITDA | 1,346 | 811.22 | 581.11 | 643.75 | 448.59 | Upgrade
|
| EBITDA Margin | 24.83% | 22.56% | 22.49% | 25.25% | 22.55% | Upgrade
|
| D&A For EBITDA | 184.26 | 154.46 | 135.19 | 115.95 | 86.37 | Upgrade
|
| EBIT | 1,162 | 656.76 | 445.91 | 527.79 | 362.22 | Upgrade
|
| EBIT Margin | 21.43% | 18.27% | 17.26% | 20.70% | 18.21% | Upgrade
|
| Effective Tax Rate | 24.61% | 22.25% | 20.67% | 23.18% | 24.88% | Upgrade
|
Updated Dec 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.